Please assess the completion status of the following clinical trial:

Trial Title: To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must be of non-childbearing potential and female patients must have a negative pregnancy test at the Screening Visit~* Histologically and/or cytologically confirmed cancer with ECOG ≤2~* Life expectancy of ≥ 3 months~* Assigned to receive the first cycle of a new multi-day chemotherapy regimen including the daily administration of cytotoxic agent(s) with the emetogenic potential of level 3-5 (Hesketh Classification) on 3-5 days~Exclusion Criteria:~* Hypersensitivity to adhesive plasters~* Contraindications to 5-HT3 receptor antagonists~* Clinically relevant abnormal laboratory values or hepatic, renal, infectious, neurological or psychiatric disorders or any other major systemic illness at the discretion of the Investigator~* Any cause for nausea and vomiting other than CINV~* Clinically relevant abnormal ECG parameters~* Concomitant radiotherapy of total body, brain or upper abdomen within one week of study entry or planned during the study~* A patient taking a medication to control the symptoms of a brain tumour, brain metastasis or seizure disorder

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).